Acquirer(s)
- Bayer Ag Germany
Target(s)
- Roche Pharmaceutical
Summary
The acquisition will lead to only a small increase in Bayer's market share in the over-the-counter pharmaceutical market in Australia. In addition, the merged entity is likely to face competition from a number of domestic and multinational pharmaceutical companies that are currently active in the Australian market.Market definition
The relevant market was considered to be the national market for the development, manufacturing, and supply of over-the-counter pharmaceutical products.Competition analysis
The acquisition will lead to only a small increase in Bayer's market share in the over-the-counter pharmaceutical market in Australia. In addition, the merged entity is likely to face competition from a number of domestic and multinational pharmaceutical companies that are currently active in the Australian market.Merger type
Asset Sale
Guidelines thresholds
Below
Imports above 10%
Yes
Initiation
Parties
ANZSIC code
5251